Personalized Medicine (ISSN: 1741-0541)

Description

Personalized Medicine (ISSN 1741-0541) translates recent genomic, genetic and ‘omic advances into the clinical context. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations and others in the healthcare community. Personalized Medicine assists these parties to shape the future of medicine by providing a platform for expert commentary and analysis.
The journal addresses scientific, commercial and policy issues in the field of precision medicine and includes news and views, current awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles. Articles submitted to Personalized Medicine are subject to rigorous peer review. Topics addressed include:
Advances in molecular diagnostics
Biochip/microarray technologies
Biological therapies or vaccine approaches at specific genetic and immunologic targets
Cost-benefit issues for precision medicine
Ethics in precision medicine
Impact of precision medicine on healthcare and the pharmaceutical industry
Impact of the latest concepts of development of precision medicine based on pharmacogenomics, pharmacogenetics and pharmacoproteomics
Incorporation of genetic analysis in clinical trials methodology
Integration of diagnosis with therapy
Legal issues in personalized medicine
Prediction of adverse reactions of drugs and drug safety
Treatment monitoring
Therapeutic applications of genome editing and associated technologies